当前位置:首页 - 行情中心 - 联盛化学(301212) - 财务分析 - 利润表

联盛化学

(301212)

  

流通市值:23.73亿  总市值:27.33亿
流通股本:9375.00万   总股本:1.08亿

利润表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、营业总收入407,646,305.88186,333,437.69693,391,059.26505,901,814.13
  营业收入407,646,305.88186,333,437.69693,391,059.26505,901,814.13
二、营业总成本385,982,783.76177,992,271.4682,334,546.01496,867,187.24
  营业成本341,036,577.5156,154,683.43612,809,928.74451,046,534.4
  税金及附加2,511,197.611,280,222.224,526,015.652,905,097.97
  销售费用4,873,415.032,060,295.429,091,486.236,574,107.65
  管理费用21,018,045.5810,723,674.3933,131,710.5823,049,734.62
  研发费用14,196,925.536,572,073.7125,062,567.3215,861,723.04
  财务费用2,346,622.511,201,322.23-2,287,162.51-2,570,010.44
  其中:利息费用73,377.8546,230.01101,423.0359,659.15
  其中:利息收入1,415,659.78341,832.384,921,324.113,743,271.54
三、其他经营收益
  加:公允价值变动收益-578,884.86-201,866.99-638,292.28-272,592.8
  加:投资收益217,314.15188,267.191,353,167.55999,879.5
  资产处置收益--17,414.0517,414.05
  资产减值损失(新)-61,366.71-394,774.8353,407.78-563,744.96
  信用减值损失(新)280,651.81-830,430.24991,245.691,948,241.67
  其他收益1,552,252.58856,742.494,903,077.683,256,944.16
四、营业利润23,073,489.097,959,103.9117,736,533.7214,420,768.51
  加:营业外收入900.6900.6367,876.9124,428.95
  减:营业外支出34,369.0213,166.34775,051363,042.98
五、利润总额23,040,020.677,946,838.1717,329,359.6214,182,154.48
  减:所得税费用1,956,878.19837,988.18886,184.62415,008.15
六、净利润21,083,142.487,108,849.9916,443,17513,767,146.33
(一)按经营持续性分类
  持续经营净利润21,083,142.487,108,849.9916,443,17513,767,146.33
(二)按所有权归属分类
  归属于母公司股东的净利润19,026,460.776,091,187.5213,852,616.1412,414,342.07
  少数股东损益2,056,681.711,017,662.472,590,558.861,352,804.26
  扣除非经常损益后的净利润18,995,979.346,009,084.0811,371,614.0310,304,339.8
七、每股收益
  (一)基本每股收益0.180.060.130.11
  (二)稀释每股收益0.180.060.130.11
九、综合收益总额21,083,142.487,108,849.9916,443,17513,767,146.33
  归属于母公司股东的综合收益总额19,026,460.776,091,187.5213,852,616.1412,414,342.07
  归属于少数股东的综合收益总额2,056,681.711,017,662.472,590,558.861,352,804.26
公告日期2026-08-272026-04-242026-04-242025-10-30
审计意见(境内)标准无保留意见
TOP↑